Search

Recainam

The usage of the INN stem '-cain-' in the name indicates that Recainam is a class I antiarrhythmic, procainamide and lidocaine derivative. Recainam has a monoisotopic molecular weight of 263.2 Da.

Milacainide

The usage of the INN stem '-cain-' in the name indicates that Milacainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

Myristyl glyceryl ether

Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)-

Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)- is under investigation in clinical trial NCT00545454 (Activity and Safety of Oral Administration of SSR150106XB for

Nelistotug

Neck- GALAXIES H&N-202). … in clinical trial NCT06062420 (A Platform Study of Novel Immunotherapy Combinations as First-line Treatment in Participants With PD-L1 Positive Recurrent/metastatic Squamous Cell Carcinoma of the Head and

Alpibectir

Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide).

Sarconeos

Sarconeos is an activator of the MAS receptor.

Lestaurtinib

NRP290

NRP290 is a hydrocodone derivative under investigation for the treatment of pain (moderate to moderately severe).

Lanifibranor

Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).